ANAL CANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL CANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL CANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL CANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new trial tests gentler treatment for anal cancer
Disease control OngoingThis phase II trial is testing whether a lower dose of chemotherapy plus radiation can work as well as the standard dose for early-stage anal cancer. The study includes 252 adults with T1-2N0M0 anal cancer. The goal is to see if the gentler approach controls the disease while imp…
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy combo shows promise for tough anal cancer
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in people with anal cancer that has spread and not responded to prior treatment. The goal is to see if these drugs can shrink tumors or slow cancer growth. About 143 adults with advanced squamous cell carcinoma o…
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks Cancer's genetic secrets during therapy
Knowledge-focused OngoingThis research study looks at how certain cancers (head and neck, esophagus, and anal canal) change at the genetic and immune level when patients receive chemotherapy or immunotherapy. About 39 people with advanced cancer will provide blood samples and tumor tissue over time. The …
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC